ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • “Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.

  • “Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.

  • “Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • “Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.

  • “Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.

  • “Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.

  • “Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

 

 

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Wei Liu Hunan, University of Chinese Medicine, China

Prof. Dr. Wei Liu is a distinguished scholar in Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, serving as Deputy Dean at Hunan University of Chinese Medicine. With a Ph.D. in Engineering 🎓, he has made groundbreaking contributions through 100+ research papers 📄 (30+ indexed in SCI/EI), 2 monographs 📚, and 9 textbooks 📖. His 30+ software copyrights 💡 and leadership in 20+ major projects 🚀, including collaborations with Huawei and national research foundations, solidify his expertise. As a Young Backbone Teacher of Hunan Province, he also excels in mentoring, guiding students to 300+ awards 🏅, including 10+ national gold prizes 🏆. His teaching innovation has earned him national and provincial-level honors, while his contributions to Traditional Chinese Medicine (TCM) Informatics 🌿 further highlight his multidisciplinary excellence. Recognized as a National Certified System Architect 🏗️, SCI journal reviewer 🧐, and a member of CCF, ACM, and CAIS, Prof. Liu is a true leader in his field.

Publication Profile

Scopus

Education

Prof. Dr. Wei Liu holds a Ph.D. in Engineering (Computer Application Technology) 🖥️ from a prestigious institution, where he specialized in Artificial Intelligence 🤖 and Medical Informatics 🏥. His doctoral research focused on intelligent software systems, integrating machine learning 📊 with healthcare applications 🏩. Prior to his Ph.D., he completed his Master’s degree 🎓 in Computer Science, gaining deep expertise in data-driven decision-making 💾 and intelligent algorithms 🔍. His academic journey also includes undergraduate studies in Software Engineering 💡, where he built a strong foundation in computational intelligence 🧠, biomedical computing 🏥, and software development 💻. With an interdisciplinary education spanning engineering, computer science, and informatics, Prof. Liu combines technical depth with practical innovation, making his academic background perfectly suited for pioneering AI-driven healthcare solutions 🚑. His commitment to education 📚 continues as he mentors students and professionals in next-generation AI research and applications 🤖📊.

Experience

Prof. Dr. Wei Liu serves as the Deputy Dean of the School of Informatics 🏛️ at Hunan University of Chinese Medicine, leading research in Artificial Intelligence 🤖, Medical Informatics 🏥, and Software Engineering 💻. As a Professor and Senior Engineer 👨‍🔬, he supervises Master’s students 🎓, guiding them in cutting-edge AI research 🚀. With a rich teaching career 📚, he has developed three top-level provincial courses 🎖️ and ranked 1st in the Hunan Provincial Teaching Competition 🏆. His industry collaborations with Huawei and leadership in 20+ national projects 🏗️ highlight his practical impact 🌍. He actively contributes as a Vice President of the Hunan Association for TCM Informatics 🌿 and serves on multiple national AI and computing committees 🤝. His work as an SCI journal reviewer 🧐 and National Certified System Architect 🏗️ ensures that his research, teaching, and innovation continue to shape the future of AI-driven medical solutions 🔬.

Awards & Honors

Prof. Dr. Wei Liu is a distinguished researcher and educator 🌟, renowned for his contributions to AI, medical informatics, and teaching innovation 📚. His accolades include the National Teaching Innovation Competition Second Prize 🏆 (2024), 1st Place in the Hunan Provincial Teaching Competition 🎖️, and the National TCM Informatics Teaching Gold Prize 🏅. He has been honored as the “Most Knowledgeable Young Teacher” in Hunan Province 🏆 and recognized as a Young Backbone Teacher 👨‍🏫. A recipient of the Huawei Industry-Academia Collaboration Excellence Award 🏅, he also serves as an Executive Member of National AI Committees 🤖. His mentorship has led students to win 300+ awards 🏆, including over 10 national gold prizes 🥇. As a pioneer in AI-driven medical technologies 🌍, his impact extends across academia and industry 🚀.

Research Focus

Prof. Dr. Wei Liu’s research spans Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, focusing on AI-driven healthcare solutions 📊, big data analysis 🏩, and intelligent diagnosis 🏥. His expertise includes AI-based disease prediction, NLP for medical data 📜, deep learning for medical imaging 🧠📸, and IoT-driven smart healthcare 🚑. Integrating AI with Traditional Chinese Medicine 🌿🤖, he pioneers innovative patient care solutions. With 30+ software copyrights 💡, 100+ high-impact publications 📄, and national-level projects—including Huawei collaborations 🚀—his work enhances precision medicine, diagnostics, and medical software applications 🌍, revolutionizing healthcare technology.

Publication Top Notes

Recognition of Hand-Drawn Hydrocarbon Structure Formulas Using Anchor-Free Detector

Classification of cold and hot medicinal properties of Chinese herbal medicines based on graph convolutional network

ChemReco: automated recognition of hand-drawn carbon–hydrogen–oxygen structures using deep learning

SQCS: A sustainable quality control system for spatial crowdsourcing via three-party evolutionary game: Theory and practice

Truth based three-tier Combinatorial Multi-Armed Bandit ecosystems for mobile crowdsensing

YoDe-Segmentation: automated noise-free retrieval of molecular structures from scientific publications

 

Christiani Amorim | Medicine and Health Sciences | Hypothesis Achievement Award

Christiani Amorim | Medicine and Health Sciences | Hypothesis Achievement Award

Assoc Prof Dr Christiani Amorim, Université catholique de Louvain, Belgium

Publication profile

google scholar

Education

Assoc. Prof. Dr. Christiani Amorim holds a Ph.D. in Veterinary Medicine from the Federal University of Santa Maria (2006), an M.Sc. in Production and Reproduction in Small Ruminants from the State University of Ceará (1998), and a B.Sc. in Veterinary Medicine from the State University of Ceará (1995).

Work Experience

Dr. Amorim is currently a Professor and Honorary FNRS Research Associate at the Catholic University of Louvain in Brussels, Belgium, and the Chief Scientific Officer at ProFaM in Birmingham, UK. She has held numerous academic and research roles, including Adjunct Faculty at Southern Illinois University (2021-2024) and FNRS Research Associate at the Catholic University of Louvain (2014-2020).

Teaching

She has been lecturing in various subjects since 2023 at Université Catholique de Louvain, including courses in reproductive systems, histology, and pathophysiology. Previously, she taught veterinary obstetrics and special topics in animal biology at the University of Brasília.

Commission of Trust

Dr. Amorim has served on multiple committees, including as a member of the Conseil Equity, Diversity, Inclusion, and as Director of the Research Pole in Physiopathology of Reproduction at Université Catholique de Louvain. She was also the President of the Society of Low Temperature Biology from 2020-2023.

Event Organization

She has organized and participated in numerous international conferences and workshops, such as CRYO2024 and the 61st Annual Meeting of the Society for Cryobiology, reflecting her leadership in the field.

Editorial Board Member

Dr. Amorim is an editorial board member and associate editor for several prestigious journals, including Reproductive Biology and Endocrinology and Journal of Fertility Preservation, showcasing her expertise and influence in reproductive health research.

Ad-hoc Reviewer

She has reviewed articles for a wide range of scientific journals, such as Human Reproduction and Acta Biomaterialia, contributing significantly to the peer-review process in her field.

Grant Reviewer

Dr. Amorim has reviewed grants for organizations like the European Commission and the Deutsche Forschungsgemeinschaft, highlighting her role in advancing scientific research through rigorous evaluation.

Project Grants

She has been involved in several significant research projects, including the PROVIDE project on in vitro folliculogenesis and spermatogenesis, supported by substantial funding from various organizations.

Other Meriting Academic Missions

Dr. Amorim has delivered numerous invited talks at prestigious international conferences, sharing her research on reproductive tissue engineering and fertility preservation.

Awards/Recognition

Her contributions to science have been recognized with numerous awards, including being listed among the top 25 World Experts in Fertility by ExpertScape and as one of the top 2% scientists worldwide by Elsevier. She also received the 3M Award “25 Women in Science in Latin America” in 2021 and the Royan International Research Award for best research in Female Infertility in 2014.

Conclusion

With extensive academic qualifications, groundbreaking research in fertility and reproductive health, leadership roles, and numerous awards, Assoc. Prof. Dr. Christiani Amorim is an exemplary candidate for the Research for Hypothesis Achievement Award. Her innovative work and significant contributions to the field make her highly suitable for this honor.

research focus

Based on the research papers listed, the focus of this person’s research is on ovarian tissue cryopreservation, including methods for preserving and transplanting ovarian tissue. Their work covers various aspects, such as the safety and efficacy of reimplantation of cryopreserved ovarian tissue, vitrification techniques, and the survival of pre-antral follicles after cryopreservation. They have also explored the development of biodegradable scaffolds for ovarian cell transplantation and reviewed the progress of ovarian tissue banks. This research is crucial for female fertility preservation, particularly for patients undergoing treatments like chemotherapy. 🌟🧬❄️

Publication top notes

Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe

Vitrification as an alternative means of cryopreserving ovarian tissue

Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix

A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold

Transplantation of an alginate–matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles …

A review of 15 years of ovarian tissue bank activities

Cryopreservation of human ovarian tissue: a review

Vitrification and xenografting of human ovarian tissue

Cryopreservation of ovarian tissue: an emerging technology for female germline preservation of endangered species and breeds